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http://www.cmjournal.org/content/9/1/15RESEARCH Open AccessCordyceps cicadae induces G2/M cell cycle arrest
in MHCC97H human hepatocellular carcinoma
cells: a proteomic study
Hualin Wang1,2, Jing Zhang1, Wai-Hung Sit1, Chung-Yung Jetty Lee1 and Jennifer Man-Fan Wan1*Abstract
Background: Cordyceps cicadae is a medicinal fungus that is often used for treating cancer. However, the
anticancer mechanisms of C. cicadae are largely unknown. This study aims to investigate the anticancer
mechanisms of C. cicadae against hepatocellular carcinoma cells in vitro using a proteomic approach.
Methods: Human hepatocellular carcinoma MHCC97H cells were treated with a water extract of C. cicadae
(0, 100, 250, 500, and 1000 μg/mL) for 48 h and harvested for cell viability assays. The significant differences in
protein expression between control and C. cicadae-treated cells were analyzed by two-dimensional gel-based
proteomics coupled with matrix-assisted laser desorption ionization-time of flight mass spectrometry. Flow
cytometry analysis was employed to investigate the cell cycle and cell death. The anticancer molecular mechanism
was analyzed by whole proteome mapping.
Results: The water extract of C. cicadae (0, 100, 250, 500, and 1000 μg/mL) inhibited the growth of MHCC97H cells
in a dose-dependent manner via G2/M phase cell cycle arrest with no evidence of apoptosis. Among the identified
proteins with upregulated expression were dynactin subunit 2, N-myc downstream-regulated gene 1, heat shock
protein beta-1, alpha-enolase isoform 1, phosphatidylinositol transfer protein, and WD repeat-containing protein 1.
Meanwhile, the proteins with downregulated expression were 14-3-3 gamma, BUB3, microtubule-associated protein
RP/EB family member 1, thioredoxin-like protein, chloride intracellular channel protein 1, ectonucleoside triphosphate
diphosphohydrolase 5, xaa-Pro dipeptidase, enoyl-CoA delta isomerase 1, protein-disulfide isomerase-related chaperone
Erp29, hnRNP 2H9B, peroxiredoxin 1, WD-40 repeat protein, and serine/threonine kinase receptor-associated protein.
Conclusion: The water extract of C. cicadae reduced the growth of human hepatocellular carcinoma MHCC97H cells
via G2/M cell cycle arrest.Background
Primary liver cancer accounted for 6% of the total cancer
cases worldwide in 2008 [1]. The highest incidences of liver
cancer were in East Asia (Japan, Korea, and China) [2,3]. In
China, liver cancer has the third highest estimated age-
standardized cancer incidence rate in men and the fourth
in women, and the second and third highest cancer mortal-
ity rates in men and women, respectively [1]. The high inci-
dence of liver cancer in China is attributed to consumption
of aflatoxin-contaminated grains, liver virus infection, and
alcohol drinking [3]. Hepatitis B vaccination can* Correspondence: jmfwan@hku.hk
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unless otherwise stated.effectively prevent liver cancer, but the treatment of
liver cancer is still difficult [3,4].
Chinese medicine (CM) has been widely used in con-
junction with chemotherapeutic drugs for liver cancer
treatment in China with positive outcomes [5]. Cordy-
ceps is a genus of ascomycete fungi belonging to the
Clavicipitaceae family. All Cordyceps species are endo-
parasitoids, and most of them parasitize insects and
other arthropods. The Cordyceps genus includes nearly
400 species, and some of them have potential anticancer
effects. Cordyceps sinensis is a medicinal fungus that has
been used for cancer treatment in CM and Traditional
Tibetan medicine since the 15th century [6,7]. The anti-
cancer properties of C. sinensis via cancer cell apoptosis
induction, proliferation inhibition, or both in varioustd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Wang et al. Chinese Medicine 2014, 9:15 Page 2 of 12
http://www.cmjournal.org/content/9/1/15types of cancers, including leukemia, melanoma, Leydig
tumor, breast cancer, and human hepatocellular carcinoma
(HCC) have been investigated [8-10]. C. sinensis inhibited
tumor metastasis in vivo [11,12]. Another well-known
species, Cordyceps militaris, showed anticancer effects
on leukemia, lung cancer, and breast cancer in vitro and
in vivo [13-17], and its bioactive compound, cordycepin,
exhibited cytotoxic and reactive oxygen species-generating
activity in relation to cancer proliferation inhibition [18-22].
Cordyceps cicadae, another well-known medicinal mush-
room that grows on larvae of Cicadae flammata, has been
used in CM in China for the prevention and treatment of
various diseases, including kidney disease, immune disease,
and cancer [23-25]. C. cicadae exhibited immunoregulatory
effects on human T lymphocytes and modulated the
growth of mononuclear cells [26-29]. C. cicadae inhibited
the growth of lung adenocarcinoma and melanoma in vivo
and in vitro [30,31]. However, the anticancer mechanism of
C. cicadae for liver cancer is still unknown.
In the last decade, proteomics has been widely used
in medical studies for clinical biomarker identification,
pathogenesis investigation, new drug discovery, pharmaco-
logical research, toxicological examination, and so on [32].
Most biological functions are transmitted via proteins
such as enzymes, receptors, and structural components.
Therefore, comprehensive proteomic analyses help us to
understand the molecular modifications in physiological
conditions [33]. This study aims to investigate the anti-
cancer mechanisms of C. cicadae against HCC in vitro
by two-dimensional gel-based proteomics coupled with
matrix-assisted laser desorption ionization-time of flight
(MALDI-TOF/TOF) mass spectrometry (MS), flow cy-
tometry analysis, and proteome mapping.
Materials and methods
Cell culture and reagents
The MHCC97H cell line was purchased from the Liver
Cancer Institute of Fudan University (China). MHCC97H
cells were cultured in DMEM (Gibco BRL, USA) supple-
mented with 10% fetal bovine serum (Gibco BRL) in a hu-
midified incubator containing 5% CO2 in air at 37°C, and
subcultured with 0.25% trypsin-0.02% EDTA (Gibco BRL).
A lyophilized hot water extract of wild-type C. cicadae
(BioAsia Co., China) was dissolved in phosphate-buffered
saline (PBS) and adjusted to a final concentration of
10 mg/mL.
Cell proliferation assay
The dose-dependent effect of C. cicadae on cell viability
was assessed by the MTT assay. Briefly, suspended
MHCC97H cells (1 × 105 cells/mL; 100 μL) were dispersed
into the wells of 96-well microtiter plates. After 24 h of in-
cubation, various concentrations of C. cicadae were added
to each well and incubated for 48 or 72 h. Next, 10 μL ofMTT solution (5 mg/mL 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide dissolved in c-DMEM)
(USB Corporation, USA) was added to each well, and
incubated for 3 h at 37°C. The MTT solution was then
removed and the insoluble purple formazan crystals formed
were dissolved in 50 μL of isopropanol in 0.1 M HCl
(MERCK, Germany). The optical density (OD) of each
well was measured using a Bio-Rad 550 Microplate Reader
(Bio-Rad, USA) at 595 nm with a reference wavelength of
655 nm. The percentage of cell viability was expressed as
(Atreatment / Acontrol) × 100%.
Cell cycle analysis
The dose-dependent effect of C. cicadae on the cell cycle
distribution was assessed by flow cytometry as described
in our previous report [34]. Briefly, MHCC97H cells
(1 × 105 cells/mL) were treated with various concentra-
tions of C. cicadae (0, 100, 250, 500, and 1000 μg/mL)
for 48 h, and the cells were then harvested, fixed in 70%
ethanol (MERCK, Germany), and stored at −20°C for
24 h until further analysis. Next, the cells were washed
twice with ice-cold PBS, and incubated with RNase and
propidium iodide (PI) (Sigma-Aldrich, USA) for 30 min.
The PI-stained cells were excited at a wavelength of
488 nm and emitted at a maximum wavelength of 617 nm.
Acquisition of 10,000 events was chosen for measurement
of the DNA cell cycle distribution using a COULTER XL
Flow Cytometer (Beckman and Coulter, USA). The distri-
bution of cells in the different cell cycle phases shown in
the DNA histograms was analyzed using Becton Dickinson
Cell Fit Software (BD, USA).
Sample preparation for proteomic analysis
MHCC97H cells were seeded in 100-mm culture dishes at
1 × 106 cells/dish (1 × 105 cells/mL), incubated overnight,
and then treated with or without 500 μg/mL C. cicadae
for 48 h. The cells were harvested by trypsinization, washed
three times with PBS, and centrifuged in a Beckman
Spinchron DLX (Beckman and Coulter) at 400 × g for
5 min. The cell pellet was resuspended in lysis buffer
[1% Triton X-100 (USB Corporation), 25 mmol/L 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES;
Sigma-Aldrich), 150 mmol/L NaCl (UNIVAR, USA),
1 mmol/L EDTA disodium salt (Sigma-Aldrich), 1 mmol/L
dithiothreitol (DTT; USB Corporation)] with Protease
Inhibitor Cocktail Set III (AEBSF, aprotinin, bestatin,
E-64, leupeptin hemisulfate, pepstatin A; Bio-Rad). The
superfluous salt in the extract was removed by incubation
with trichloroacetic acid (TCA)-acetone solution [20% TCA
(MERCK, Germany), 20 mmol/L DTT in acetone (MERCK,
Germany)] for 4 h at −40°C. The protein pellet was obtained
by centrifugation at 15,800 × g for 30 min at 4°C. Excess
TCA was removed by three washes with acetone con-
taining 20 mmol/L DTT. The air-dried protein pellet was
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2 mol/L thiourea (Sigma-Aldrich), 4% 3-[(3-cholami-
dopropyl)dimethylammonio]-1-propanesulfonate (CHAPS;
Sigma-Aldrich), 100 mmol/L DTT, 5% glycerol (USB
Corporation)], and the protein solution was stored at −80°C
until 2-DE analysis. The protein concentration was de-
termined by the Bradford assay (Bio-Rad).
Two-dimensional electrofocusing and polyacrylamide gel
electrophoresis
The 2-DE procedures were carried as described in our
previous report with modifications [35]. The samples
were examined in duplicate and 12 gels (6 for control cells
and 6 for C. cicadae-treated cells) were used in total. For
the first-dimensional electrophoresis of proteins, protein
samples (150 μg) were mixed with 350 μL of rehydration
buffer [9.5 mol/L urea, 2% CHAPS, 0.28% DTT, 1% immo-
bilized pH gradient buffer with pH 3–10 (Bio-Rad), 0.002%
bromophenol blue (Sigma-Aldrich)] and then rehydrated
for 10 h before isoelectric focusing via the following
program: (a) linear increase up to 500 V in 1 h; (b) held
at 500 V for 2 h; (c) linear increase up to 10,000 V in
4 h; (d) linear increase up to 10,000 V in 3 h; (e) held
at 10,000 V to reach a total of 90,000 V × h. Focused
immobilized pH gradient (IPG) gel strips were equilibrated
for 15 min in a solution [50 mmol/L Tris–HCl, pH 8.8
(Bio-Rad), 6 mol/L urea, 30% glycerol, 2% sodium dodecyl
sulfate (SDS; USB Corporation), containing 20 mmol/L
DTT], followed by incubation with the same buffer
containing 20 mmol/L iodoacetamide (Sigma-Aldrich)
for another 15 min. The second-dimensional separation
was performed in 1-mm-thick 12.5% polyacrylamide gels
by sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis (SDS-PAGE) at 15-mA current for 30 min followed
by 30-mA current for the rest of the analysis.
Image acquisition and analysis
After the electrophoresis, the gels were stained with
SYPRORuby Protein Stain (Bio-Rad), scanned with a
Molecular Imager PharosFX Plus System (Bio-Rad),
and analyzed using PDQuest 8.0 (Bio-Rad) according
to the following procedures: background subtraction,
spot detection, and spot matching. The expression levels,
expressed as the percentage volume (% vol), were exported.
The relative intensities of spots were used for comparisons
between the two groups and only those spots with a signifi-
cant difference (>1.5-fold increase or decrease, P < 0.05)
were selected for protein identification.
Protein identification
Spots with differential expression (P < 0.05) after 500 μg/mL
C. cicadae treatment were sent to the Genome Research
Centre (The University of Hong Kong, Hong Kong) for pro-
tein identification by MALDI-TOF/TOF MS (4800 MALDITOF/TOF Analyzer; Applied Biosystems, USA) analysis
after trypsin digestion. The identification was performed
by Mascot peptide mass fingerprinting, which can identify
proteins from the NCBInr database with taxonomy limited
to Homo sapiens. Mascot reported the molecular weight
search (MOWSE) score, which was calculated as −10 × log10
(P), where P is the probability that the observed match is a
random event. P was limited by the size of the sequence
database being searched (limited by taxonomy), with con-
ditions such as peptide fixed modification and variable
modification and the settings for trypsin digestion. Each
calculated value that fell within a given mass tolerance of
an experimental value counted as a match. The threshold
was accepted if an event occurred at random with a fre-
quency of < 5%. In this study, a protein match with a score
of > 71 was regarded as significant.
Western blot analysis
Western blot analysis was performed with Mighty Small II
SE250/260 Cell (Hoefer, USA) and TE 77 PWR Trans-
fer (GE Healthcare, USA) electrophoresis units. Briefly,
MHCC97H cells treated with or without various concentra-
tions of C. cicadae (0, 100, 250, and 500 μg/mL) for 48 h
were harvested, washed twice with PBS, and lysed in the
lysis buffer for sample preparation described above. The
lysates were centrifuged at 11000 × g for 30 min. The total
protein concentration in the supernatant was determined
by the Bradford assay (Bio-Rad). For immunoblotting, each
protein extract was mixed with sample buffer [62.5 mmol/L
Tris, pH 6.8 (Bio-Rad), 25% glycerol, 2% SDS, 350 mmol/L
DTT, 0.01% bromophenol blue] at a ratio of 1:1 (v/v) and
then kept in boiling water for 5 min. An aliquot (30 mg pro-
tein) of each sample was applied for electrophoresis in 12.5%
SDS-PAGE gels with constant voltage (120 V) and trans-
ferred to a polyvinylidene difluoride membrane (GE Health-
care). The membranes were blocked with 5% skimmed milk
in PBST [PBS, pH 7.4, 0.1% Tween-20 (USB Corporation)]
for 3 h at room temperature, followed by incubation for 2 h
with the following primary antibodies (ABCAM, UK): anti-
CDK1 (ab32384; 1:2000); anti-cyclin B1 (ab32053; 1:2000);
anti-HSP27 (ab2790; 1:2000); anti-PRDX1 (ab16805; 1:2000);
anti-STRAP (ab46784; 1:2000). The membranes were
washed three times with PBST, and incubated with HRP-
conjugated goat anti-rabbit or anti-mouse IgG (Bio-Rad;
1:10 000) for 1 h at 37°C. After three washes with PBST,
the membranes were developed using Inmun-Star HRP
peroxide buffer (Bio-Rad). The relative molecular weight of
each protein band was estimated using molecular markers
(Precision Plus Protein Standards Dual Color; Bio-Rad).
Each sample was measured three times.
Statistical analysis
In cell proliferation assay, experiments were repeated three
times, measurements within an experiment were done in
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were repeated three times. Data from three independ-
ent experiments were expressed as mean ± standard de-
viation (SD). The significance of differences in data was
determined by Kruskal-Wallis one-way analysis of vari-
ance (ANOVA) followed by Dunnets post hoc test for
determination of dose–response dependence. In prote-
omic analysis, six individual samples were prepared and
run for 2D gel in each group (i.e., n = 6) the significance
of differences in data was determined by a two-tailed
Student’s t-test with Levene’s test for equality of vari-
ances. All analyses were performed using SPSS 17.0
(IBM, USA) with P < 0.05 as the significance level.
Results
Effects of C. cicadae on MHCC97H cell proliferation
MHCC97H cells were grown in medium containing
various concentrations of C. cicadae (0, 100, 250, 500,
and 1000 μg/mL) for 48 or 72 h to investigate the effects
of C. cicadae on cell proliferation. Dose-dependent in-
hibition of cell growth was observed with treatment of
C. cicadae (P < 0.05) (Figure 1).
Effect of C. cicadae on the cell cycle distribution of
MHCC97H cells
Figure 2A shows the effects of C. cicadae (0, 100, 250, 500,
and 1000 μg/mL) treatment for 48 h on the cell cycle phase
distribution of MHCC97H cells. As shown in Figure 2B,
treatment with C. cicadae (100, 250, and 500 μg/mL) for
48 h resulted in cell accumulation in G2/M phase at 23.8%,
30.2%, and 38.6%, respectively, compared with the control
cells (19.8%), and decreased the cell percentages in G0/G1
phase by 48.2%, 43.9%, and 35.6%, respectively, compared
with the control cells (53.3%). Treatment with C. cicadae atFigure 1 The effects of C. cicadae on MHCC97H cell viability.
The cell viability was tested by MTT assay. Data were expressed as
mean ± SD (n = 3 separate experiments). **,***, P < 0.01, 0.001 vs.
control in 48 h treatment group, and ##, ###, P < 0.01, 0.001 vs.
control in 72 h treatment group, respectively.100, 250, and 500 μg/mL for 48 h did not affect the cell
population in S phase (27.9%, 25.8%, and 25.9%, respect-
ively, compared with the control cells (26.91%). Further-
more, most cells (64.74%) were arrested in G2/M phase
with the highest dose of 1000 μg/mL C. cicadae. The
sub-G1 apoptotic fraction of cells showed no significant
changes when C. cicadae (100–500 μg/mL) was added,
suggesting that no apoptosis occurred during the period
of examination.
CDK1/cyclin B complex is involved in the G2/M phase
checkpoint by regulating the process of M phase [36].
Figure 3 shows that while the CDK1 protein level was
decreased in MHCC97H cells after C. cicadae treatment,
the cyclin B1 protein level was unaffected.
Differential expression of proteins in C. cicadae-treated
MHCC97H cells
2-DE analyses were performed for each treated sample
and repeated six times. Figure 4 shows representative gel
images in which more than 1000 spots were detected on
each gel. Proteins within the range of 15–225 kDa and
having isoelectric points between 3 and 10 were well sepa-
rated. Table 1 presents the differential expression levels of
the identified proteins in MHCC97H cells without (control)
and with C. cicadae treatment. Twenty-eight proteins
with significant (P < 0.05) changes of > 1.5-fold in vol-
ume intensity were selected and further analyzed by
MALDI-TOF–MS/MS for peptide identification after
trypsin digestion. Among these proteins, the nine upregu-
lated proteins were identified as tubulin beta 2C, dynactin
subunit 2 (DCTN2), keratin type II cytoskeletal 7, keratin
type I cytoskeletal 10, N-myc downstream-regulated gene
1 (NDRG1), heat shock protein beta-1 (HSPB1, Hsp27),
phosphatidylinositol transfer protein beta isoform (PITPNB),
alpha-enolase isoform 1 (ENO1), and WD repeat-containing
protein 1 isoform 1 (WDR1). The 13 downregulated
proteins were identified as 14-3-3 gamma (YWHAG),
microtubule-associated protein RP/EB family member
1 (MAPRE1), chloride intracellular channel protein 1
(CLIC1), WD-40 repeat protein (STRAP), thioredoxin-like
protein (GLRX3), ACTB protein, xaa-Pro dipeptidase
isoform 3 (PEPD), enoyl-CoA delta isomerase 1 mito-
chondrial (ECI1), protein-disulfide isomerase-related
chaperone Erp29 (ERP29), ectonucleoside triphosphate
diphosphohydrolase 5 isoform (ENTPD5), hnRNP 2H9B
(HNRNPH3), peroxiredoxin 1 (PRDX1), and mitotic check-
point protein BUB3 isoform A (BUB3). The main proper-
ties of the identified proteins were summarized in Table 2.
Western blot analyses of a few randomly selected
proteins were performed for proteomic data validation.
In agreement with the proteome changes identified by
the proteomic analysis, the expression levels of Hsp27,
peroxiredoxin 1, and WD 40 were upregulated in the
cancer cells with C. cicadae treatment at 500 μg/mL
Figure 2 The effects of C. cicadae on MHCC97H cell cycle. (A) Cellular DNA contents in C. cicadae-treated and control cells were monitored
by flow cytometry. The cell cycle distribution of sub-G1, G1, S and G2/M phase cells are presented as DNA histogram. (B) The percentage of cells
in each cell cycle phase of MHCC97H after C. cicadae treatment were shown. The data were expressed as mean ± SD and were representative of
three independent experiments. *, **, P < 0.05, 0.01, vs. control, respectively.
Figure 3 The effects of C. cicadae on cell cycle checkpoint
related proteins. C. cicadae treatment decreased the expression of
CDK1 in MHCC97H cells.
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were similar to those obtained in the proteomic analysis.
Discussion
Species in the genus Cordyceps can reduce cancer cell
proliferation [14,15,55-58], but only limited studies on liver
cancer are available. Several polysaccharides isolated from
C. cicadae exhibited antitumor and immunomodulatory
properties [14,15,55-58] but the mechanisms have not
been fully explored. In the present study, we showed that
C. cicadae inhibited the growth of the human HCC cell
line MHCC97H via G2/M cell cycle arrest. In support
Figure 4 Representative of 2-DE gel proteomic maps of MHCC97H cells with (left) or without (right) C. cicadae treatment. The labelled
spots were representative of proteins with significant change.
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expressed proteins for cell cycle regulation, mitosis,
and protein synthesis were identified by the proteomic
analysis.
Western blot analyses revealed a decrease in the level
of CDK1, which is a G2/M checkpoint cyclin. The cell
cycle measurements also indicated accumulation of cells
in G2/M phase rather than induction of apoptosis with
C. cicadae. To our knowledge, this is the first study to
demonstrate that the anticancer mechanisms of C. cicadae
involve G2/M arrest. Other studies showed that C. militaris
could induce G2/M cell cycle arrest in human colon cancer
HT-29 cells [37].
Figure 6 summarizes the magnitude changes in ex-
pression of the identified proteins with reference to the
control cells. 14-3-3 gamma, BUB3, DCTN2, MAPRE1,
GLRX3, and CLIC1 are thought to be involved in cell
cycle regulation, G2/M checkpoint control, microtubule
polymerization, and spindle organization during mitosis
etc. Although their mechanisms related to the G2/M cell
cycle arrest induced by C. cicadae were not clear, 14-3-3
gamma is important for cell cycle regulation and 14-3-3
gamma expression change-induced cell cycle deregulation
has been implicated in cancer formation [37]. 14-3-3
gamma blocked premature mitotic entry into G2/M
phase after DNA damage [59,60], while 14-3-3 gamma-
knockdown cells showed inhibition of cdc25C function,
which induced overriding of both the incomplete S phase
and the G2 DNA damage checkpoint [61]. Overexpression
of 14-3-3 gamma in HCC patients was associated with
extrahepatic metastasis and worse survival [62,63]. Our
proteomic data showed that C. cicadae treatment reduced
the expression of 14-3-3 gamma in the human HCC cellline MHCC97H, suggesting that the anticancer and G2/M
phase arrest effects of C. cicadae could be attributed to
14-3-3 gamma expression inhibition.
BUB3, DCTN2, and MAPRE1 are involved in spindle
checkpoint and mitosis regulation. BUB3 is a mitosis
checkpoint protein for early stages of mitosis to prevent
premature sister chromatid separation, missegregation,
and aneuploidy via regulation of anaphase-promoting
complex/cyclosome (APC/C) [38,64]. DCTN2 is involved
in functions for the microtubule anchor dynactin complex,
inactivation of the spindle checkpoint through kinetochore
disassembly, and recruitment of cell cycle regulators to
centrosomes [40,65]. MAPRE1 is involved in microtubule
polymerization, microtubule dynamics control [39], and
mitotic spindle function [66], and is dominantly expressed
in poorly differentiated HCCs [67]. The expression changes
of BUB3, DCTN2, and MAPRE1 in C. cicadae-treated
MHCC97H cells indicate a mitosis-regulatory effect of
C. cicadae, which may contribute to G2/M phase arrest.
GLRX3 maintains redox homeostasis in living cells
[41]. In GLRX3-knockout mice, embryonic fibroblasts were
arrested at G2/M phase [68]. CLIC1 is a nuclear chloride
ion channel and involved in G2/M cell cycle regulation
[42]. These findings may suggest a reason why the ex-
pression levels of GLRX3 and CLIC1 were changed in
C. cicadae-treated MHCC97H cells.
ENTPD5 is an endoplasmic reticulum (ER) enzyme that
hydrolyzes purine nucleoside diphosphates and is essential
for liver functions, and ENTPD5-deficiency resulted in
hepatocellular neoplasia [69]. Overexpression of ENTPD5
was observed in prostate cancer [43,70]. NDRG1 is a mem-
ber of the NDRG gene family, and exhibited anticancer and
metastasis-suppression effects in pancreatic cancer, colon
Table 1 Differentially expressed proteins between C. cicadae-treated and non-treated (control) MHCC97H cells
Spot
No.1
Protein name GenInfo identifier2 Protein score3 Expression quantity
(×104) control4
Expression quantity
(×104) C. cicadae
Expression change
(C. Cicadae/control)
P pI5 Mr (kDa)5
0111 14-3-3 Gamma In Complex With A Phosphoserine Peptide gi|82407948 76 33.0 ± 7.2 19.0 ± 5.3 0.58 0.0004 4.80 28.3
1217 microtubule-associated protein RP/EB family member 1 gi|6912494 219 10.0 ± 3.7 5.7 ± 2.2 0.57 0.026 5.02 30.1
1222 Chloride intracellular channel protein 1 gi|4588526 307 24.8 ± 8.4 9.3 ± 3.3 0.38 0.004112 5.02 27.2
1305 WD-40 repeat protein gi|4519417 221 42.3 ± 10.2 12.0 ± 4.1 0.28 0.001183 4.93 38.8
1427 Tubulin, beta 2C gi|23958133 188 3.6 ± 1.7 7.8 ± 4.2 2.17 0.025345 4.83 50.2
1514 Dynactin subunit 2 gi|22096346 436 9.8 ± 2.4 19.2 ± 5.8 1.97 0.000491 5.10 44.3
2303 thioredoxin-like protein gi|3646128 123 9.3 ± 5.4 3.4 ± 1.9 0.37 0.038567 5.25 37.8
2403 ACTB protein gi|15277503 444 101.7 ± 33.4 60.3 ± 18.3 0.59 0.001814 5.55 40.5
3413 N-myc downstream regulated gene 1 gi|119612570 105 9.0 ± 3.3 30.8 ± 11.8 3.44 0.00106 5.98 34.0
4102 heat shock protein beta-1 gi|4504517 368 18.1 ± 7.6 27.7 ± 10.6 1.53 0.026641 5.98 22.8
4504 xaa-Pro dipeptidase isoform 3 gi|260593665 193 8.7 ± 2.7 3.3 ± 1.2 0.38 0.027093 5.7 48.0
5101 Enoyl-CoA delta isomerase 1, mitochondrial gi|60593479 67 11.8 ± 7.8 5.8 ± 2.9 0.49 0.040511 6.00 28.9
5106 The Protein-Disulfide Isomerase Related Chaperone Erp29 gi|192987144 247 16.3 ± 6.8 9.3 ± 4.3 0.57 0.033331 7.07 27.2
5218 phosphatidylinositol transfer protein beta isoform gi|6912594 181 5.5 ± 1.9 8.5 ± 2.6 1.56 0.004165 6.41 31.8
5425 ectonucleoside triphosphate diphosphohydrolase
5, isoform
gi|119601555 181 5.9 ± 2.1 2.3 ± 0.8 0.39 0.007848 5.74 45.7
6334 hnRNP 2H9B gi|7739445 127 31.1 ± 12.6 17.4 ± 6.5 0.56 0.023 6.76 31.5
6407 alpha-enolase isoform 1 gi|4503571 349 21.4 ± 7.5 34.8 ± 12.6 1.63 0.028265 7.01 47.5
6730 WD repeat-containing protein 1 isoform 1 gi|9257257 217 9.0 ± 4.6 13.9 ± 6.3 1.54 0.01346 6.17 66.8
7122 peroxiredoxin 1 gi|55959887 79 2.7 ± 1.0 0.5 ± 0.1 0.20 0.024662 6.41 19.1
7306 mitotic checkpoint protein BUB3 isoform a gi|4757880 147 37.1 ± 17.4 22.1 ± 10.1 0.60 0.045568 6.36 37.6
1Spot no.: automatically assigned by the PDQuest software.2GenInfo identifier: sequence identification number assigned by GenBank.
3Protein score: generated by the MS identification system.
4Expression Quantity were calculated by the PDQuest software, data expressed as mean ± SD.
5Mr and pI: relative molecular mass (Mr) and isoelectric point (pI) generated by the MS system.
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Table 2 The major bio-functions of identified proteins
Protein name Protein symbol Subcellular location Protein functions Up/down regulation
Cell growth and cell cycle regulation
14-3-3 Gamma, tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein, gamma
14-3-3γ Cytoplasm G2 DNA damage checkpoint [37] ↓
mitotic checkpoint protein BUB3 isoform A BUB3 Nucleus Spindle-assembly checkpoint signalling and establishment of correct
kinetochore-microtubule attachments [38]
↓
microtubule-associated protein RP/EB family member 1 MAPRE1 Cytoplasm Microtubule polymerization [39] ↓
Dynactin subunit 2 DCTN2 Cytoplasm Modulates cytoplasmic dynein binding to an organelle, and prometaphase
chromosome alignment and spindle organization during mitosis [40]
↑
thioredoxin-like protein GLRX3 Cytoplasm Human cancer cell growth and metastasis regulation [41] ↓
Chloride intracellular channel protein 1 CLIC1 Nucleus membrane,
cell membrane
Formation of chloride ion channels, and regulation of the cell cycle [42] ↓
Anti-cancer effects
ectonucleoside triphosphate diphosphohydrolase
5, isoform
ENTPD5 Endoplasmic
reticulum lumen
Promoting glycolysis in proliferating cells in response to phosphoinositide
3-kinase signalling in the AKT1-PTEN signalling pathway [43]
↓
N-myc downstream regulated gene 1 NDRG1 Cytoplasm, nucleus,
cell membrane
Metastasis suppression [44] ↑
heat shock protein beta-1 HSPB1 Cytoplasm, nucleus Stress resistance and actin organization [45] ↑
alpha-enolase isoform 1 ENO1 Cytoplasm, cell
membrane
Multifunctional enzyme in various processes such as growth control, hypoxia
tolerance and allergic responses [46]
↑
Other functions
xaa-Pro dipeptidase isoform 3 PEPD Cytoplasm Collagen and GSH metabolism [47] ↓
Enoyl-CoA delta isomerase 1, mitochondrial ECI1 Mitochondrion matrix ↓
The Protein-Disulfide Isomerase Related Chaperone
Erp29
ERP29 Endoplasmic
reticulum lumen
Processing of secretory proteins within the endoplasmic reticulum, possibly
by participating in the folding of proteins in the ER [48]
↓
phosphatidylinositol transfer protein beta isoform PITPNB Cytoplasm,
Golgi apparatus
Catalyzes the transfer of PtdIns and phosphatidylcholine between
membranes [49]
↑
hnRNP 2H9B HNRNPH3 Nucleus Involved in the splicing process and participates in early heat shock-induced
splicing arrest [50]
↓
WD repeat-containing protein 1 isoform 1 WDR1 Cytoplasm Induces disassembly of actin filaments in conjunction with ADF/cofilin
family proteins [51]
↑
peroxiredoxin 1 PRDX1 Cytoplasm Involved in redox regulation of the cell. Reduces peroxides with reducing
equivalents provided through the thioredoxin system but not from
glutaredoxin [52]
↓
WD-40 repeat protein, serine/threonine kinase receptor
associated protein
STRAP Cytoplasm, nucleus The SMN complex plays an essential role in spliceosomal snRNP assembly in
the cytoplasm and is required for pre-mRNA splicing in the nucleus [53,54]
↓
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Figure 5 Western blotting analysis of differential expressed
proteins. With 500 μg/mL of C. cicadae treatment, the expression of
Hsp27 was upregulated and Peroxiredoxin 1 and WD 40 were up-
regulated in the cancer cells as compared to control (500 μg/mL of
C. cicadae).
Wang et al. Chinese Medicine 2014, 9:15 Page 9 of 12
http://www.cmjournal.org/content/9/1/15cancer, cervical and ovarian cancer, prostate cancer, and
breast cancer [44,71-73]. MHCC97H cells exhibited an
80% pulmonary metastatic rate when injected into nude
mice [74]. HSPB1 is a subunit of HSP27, and suppressed
cell apoptosis in MHCC97H cells via an NF-kappaB path-
way [45]. The elevation of this protein indicated some
resistance of the cancer cells, and could be responsible for
the absence of apoptosis in the C. cicadae-treated cancer
cells. ENO1, a glycolysis module protein, was overexpressed
in HCC cells [46,75], and its increased level suggests
that C. cicadae treatment increased the glycolytic activity
of the cancer cells.Figure 6 Summary of the differential expressed proteins in response
expression level after 500 μg/mL C. cicadae treatment were plotted on the
were plotted on the left hand side.A reduction in PEPD is involved in collagen and GSH
metabolism of C. cicadae. PEPD is a homodimeric imi-
nodipeptidase that releases carboxy-terminal proline
or hydroxyproline residues from oligopeptides, and is
used as a marker of non-alcoholic liver fibrosis [47,76].
ERP29 works in the early secretory pathway in the ER, and
overexpression of ERP29 resulted in higher expression of
HSP27 in breast cancer cells [48]. The reduced expression
of ERP29 is likely to be attributed to reduced ER stress with
treatment of C. cicadae.
STRAP is involved in spliceosomal mRNP assembly in
the cytoplasm and pre-mRNA splicing in the nucleus
[53]. Overexpression of STRAP was reported in several
cancers [53,77]. A STRAP-activated p53-related apoptosis-
induction effect and higher expression of STRAP in drug-
treated HCC cells were observed [54,78]. In the present
study, the expression of STRAP was reduced, which may
be related to the non-apoptotic effect of C. cicadae.
PRDX1 is a member of the peroxiredoxin family involved
in redox regulation in cells, regulation of hydrogen perox-
ide signaling through its peroxidase activity, and a protein
chaperone function. The aspect of whether the reduced
expression of PRDX1 contributes to reduced survival
of MHCC97H cells via failure in redox regulation
against reactive oxygen species remains to be determined.
Elevated expression of PRDX1 was found in various
cancers [52,79,80].
The present study has identified novel molecular sig-
natures in C. cicadae-induced cell cycle arrest and cell
death in MHCC97H cells using proteomics. Among theto C. cicadae treatment in MHCC97H. The proteins with increased
right hand side of axis, and proteins with decreased expression level
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http://www.cmjournal.org/content/9/1/15differentially expressed proteins identified, 14-3-3 gamma,
BUB3, DCTN2, MAPRE1, GLRX3, and CLIC1 may
play some significant roles in the C. cicadae-induced
G2/M phase arrest in MHCC97H cells. The identified
proteins will further enhance a molecular explanation
for the cell cycle arrest process induced by C. cicadae.
Further validation of these markers in gene knockout
studies would greatly improve our understanding of the
molecular mechanisms behind the liver cancer therapy
potential of C. cicadae.
Conclusions
The water extract of C. cicadae reduced the growth of
the human HCC cell line MHCC97H via G2/M cell
cycle arrest.
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